Feed RARE
RA
Ultragenyx Pharmaceutical
RARE · NASDAQ
$25.49 -0.74% (-$0.19)
1M -10.66%
Market Cap $2.57B
P/E Ratio -
Div. Yield -
ROE -
Bulios Fair Price
$28.67
12.5% upside
Preț actual
$25.49
Subevaluat Valoare justă Supraevaluat
Potrivit Bulios Fair Price, acțiunile RARE sunt în prezent subevaluate față de prețul lor de piață. Cum funcționează?
Piotroski F-Score Weak
2/9Valuation
47 /100
Fair P/S 3.82x
P/FCF N/A
P/B N/A
Growth
100 /100
Growing Rev. growth 22.81%
FCF growth N/A
Book val. growth N/A
Profitability
20 /100
Weak FCF margin 70.13%
Op. margin 79.49%
Gross margin 83.80%
Quality
8 /100
Poor ROA 37.53%
Asset turnover 0.44x
ROIC 43.84%
Debt
43 /100
Moderate Int. coverage -8.63x
Current ratio 2.48x
Net debt/EBITDA N/A
Stability
68 /100
Stable Profitable years 0
EPS volatility 8.40%
Beta 0.31x
Întreabă StockBot despre RARE
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Emil D. Kakkis
Employees
1,371
Headquarters
Novato
Evenimente viitoare
03 NOV.
Earnings
Upcoming earnings report